| |
 |
|
| | |
Discussion forum - BSH 2020 VIRTUAL
 Topic - Lymphoma/CLL
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER. |
|
|
| | |
|
|
|
|
Poster: 85
Visits: 48
Title: Escalated BEACOPDac as first line therapy in 100 Hodgkin lymphoma patients reduces red cell transfusion requirements and may shorten time to menstrual period recovery whilst maintaining efficacy compared to escalated BEACOPP
Authors: Anna Santarsieri , Anna Santarsieri:,Cambridge University Hospitals NHS Foundation Trust,Cambridge,United Kingdom|Katherine Sturgess:,Cambridge University Hospitals NHS Foundation Trust,Cambridge,United Kingdom|Pauline
Centre:
|
|
You must be registered to reply or comment.
|
|
ESCALATED BEACOPDAC AS FIRST LINE THERAPY IN 100 HODGKIN LYMPHOMA PATIENTS REDUCES RED CELL TRANSFUSION REQUIREMENTS AND MAY SHORTEN TIME TO MENSTRUAL PERIOD RECOVERY WHILST MAINTAINING EFFICACY COMPARED TO ESCALATED BEACOPP
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 536
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre:
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 81
Visits: 112
Title: Updated Results of a Phase Ib/II Randomised Study: Polatuzumab Vedotin (Pola) Plus Bendamustine (B) and Rituximab (R) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Authors: Elaine Kamara , L.H. Sehn, M.J. Matasar, C.R. Flowers, M. Kamdar, A.K. McMillan, M. Hertzberg, S. Assouline, T.M. Kim, W.S. Kim, M. Ozcan, B. Croft, J. Hirata, J. Cheng, G. Ku, A.F. Herrera
Centre:
|
|
|
|
